Login to Your Account

AEterna Zentaris Gets $52.5M from Cetrotide Royalty Sale

By Trista Morrison

Thursday, November 13, 2008
After selling a building, a marketed product and a subsidiary during the past year, AEterna Zentaris Inc. continued its asset monetization strategy by selling its Cetrotide (cetrorelix) royalties to Cowen Healthcare Royalty Partners LP in exchange for $52.5 million. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription